Registry-listed formulations

Miconazole Nitrate · chembl:CHEMBL1559

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 2 studies. This list may not include all unresolved or historical entries.

  • 0.25 % Miconazole Nitrate OintmentRegistry intervention

    Molecular identity unconfirmed

    View study and source
  • Miconazole Nitrate 2%Registry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Phase 2
2
50%
Phase 4
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (50.0%)
Phase 42 (50.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

Clinical Trials (4)

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
4

External References

Names & Codes

Research Codes

M-zole 3 combination packM-zole 7 dual packNSC-169434R 14,889